INSUBCONTINENT EXCLUSIVE:
Dr CK Narayan of Chart Advise has a buy call on Glenmark Pharmaceuticals Ltd
with a target price of Rs 675
The current market price of Glenmark Pharmaceuticals Ltd
Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd
price can reach the defined target
Dr CK Narayan recommended to keep stoploss at Rs 654
Glenmark Pharmaceuticals Ltd., incorporated in 1977, is a largecap company with a market cap of Rs 18567.13 crore.
Glenmark Pharmaceuticals
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7637.56 Crore to Sales Value (94.34 % of Total Sales), Other
Operating Revenue which contributed Rs 400.67 Crore to Sales Value (4.94 % of Total Sales) and Sale of services which contributed Rs 57.26
Crore to Sales Value (0.70 % of Total Sales)for the year ending 31-Mar-2017
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 2129.37 Crore, down -5.27 % from last quarter Sales
of Rs 2247.89 Crore and down -8.59 % from last year same quarter Sales of Rs 2329.39 Crore Company has reported net profit after tax of Rs
232.99 Crore in latest quarter
Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto
Company has Walker, Chandiok Co.LLP as its auditoRs As on 30-06-2018, the company has a total of 282,168,156 shares outstanding.
